IPP Bureau
Crosscope collaborates with Waleed Pharmacy to enter Oman
By IPP Bureau - April 11, 2022
Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features
Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab
By IPP Bureau - April 11, 2022
Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones
Honeywell teams with AstraZeneca to develop net-gen inhalers to combat global warming
By IPP Bureau - April 11, 2022
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid
By IPP Bureau - April 11, 2022
These distinct gut microbial signatures can be used to predict the risk of developing long Covid and diagnose long Covid in patients with persistent symptoms after the acute infection
Intuitive launches My Intuitive App
By IPP Bureau - April 11, 2022
The app serves as a single, integrated, personalized customer platform for da Vinci surgeons
Israel’s TAU breakthrough offers new hope to help people with paralysis walk again
By IPP Bureau - April 11, 2022
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
BMSF names diversity in clinical trials training program after Robert A Winn
By IPP Bureau - April 11, 2022
The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027
Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
By IPP Bureau - April 11, 2022
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas
Lonza signs manufacturing deal with Asher Biotherapeutics
By IPP Bureau - April 11, 2022
Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein
Amyris commissions industry-leading fermentation plant
By IPP Bureau - April 11, 2022
The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products
Moderna kickstarts Phase 1/2 study for influenza vaccine candidate
By IPP Bureau - April 11, 2022
Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle
Venkaiah Naidu inaugurates India’s first ‘integrated diagnostics’ facility
By IPP Bureau - April 11, 2022
Mahajan Imaging, which currently has 10 high-end medical diagnostic centres in Delhi-NCR and Jaipur, has ventured into a new field called Integrated Diagnostics
AstraZeneca Chennai centre repositioned as Global Innovation and Technology Centre
By IPP Bureau - April 10, 2022
With close to 2,800 highly skilled employees, GITC is now one of the largest technology centres across the Life Sciences industry in the country
New research on drug-induced gene signatures for colorectal cancer patients
By IPP Bureau - April 10, 2022
Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes
Innovative therapy that ‘tricks’ and destroys cancer cells advance to clinical trial
By IPP Bureau - April 10, 2022
Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
